Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose 5% provides a source of carbohydrates for metabolism, increasing blood glucose levels and serving as a caloric supplement. Sodium chloride 0.11% supplies electrolytes to maintain osmolality and fluid balance. The combination restores intravascular volume and corrects hyponatremia or hypochloremia.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion; dose determined by clinical condition and fluid/electrolyte requirements; typical maintenance: 100-200 mL/hour for adults (provides 5-10 g glucose and 0.11-0.22 g sodium chloride per hour); adjust rate based on patient status.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateNot applicable as a composite entity. Dextrose: rapid clearance from plasma (half-life ~15-30 minutes) due to cellular uptake and metabolism. Sodium: no defined half-life; plasma sodium concentration is tightly regulated by renal function and ADH/aldosterone. Clinical context: infusion effects are immediate and sustained during administration; after discontinuation, plasma levels of glucose and electrolytes return to baseline within hours depending on metabolic and renal function.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose and sodium chloride are endogenous substances. Dextrose is metabolized via glycolysis and the citric acid cycle, ultimately producing CO2 (exhaled via lungs) and water. Renal excretion of intact glucose is negligible in euglycemia but occurs when blood glucose exceeds renal threshold (~10 mmol/L). Sodium and chloride are freely filtered at the glomerulus and extensively reabsorbed (≥99% for sodium) in the renal tubules; excretion is regulated by hormonal and hemodynamic factors. No biliary/fecal elimination of intact drug.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."